Bicara Therapeutics (BCAX) Shareholder's Equity (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Bicara Therapeutics 1.25 Bn 1.25 Bn - 513.96 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 513.96 Mn
Dec 31, 2025 401.45 Mn
Sep 30, 2025 402.78 Mn
Jun 30, 2025 435.20 Mn
Mar 31, 2025 458.96 Mn
Dec 31, 2024 491.88 Mn
Sep 30, 2024 509.56 Mn
Jun 30, 2024 -174.78 Mn
Mar 31, 2024 -160.08 Mn
Dec 31, 2023 -148.77 Mn
Sep 30, 2023 -137.11 Mn